News

Kaftrio helps CF adults build fat stores, boost muscle mass: Study

Treatment with Kaftrio (elexacaftor/tezacaftor/ivacaftor) helps increase fat stores in adults with cystic fibrosis (CF), especially those who are underweight, a study found. Researchers also found small, though statistically significant, increases in muscle mass in patients who started on Kaftrio. The results showed that Kaftrio mainly affects fat tissues,…

CF community needs clearer cross infection information: Survey

About every fourth member of the cystic fibrosis (CF) community feels they’re not provided clear information about cross infection and infection prevention and control, according to a survey conducted in 13 countries. Many survey respondents, mostly girls and women, said they’d wash and disinfect their nebulizers more frequently if…

Trikafta patients lower treatment burden, cut other therapies: Study

After starting Trikafta, people with cystic fibrosis (CF) significantly reduced their use of other CF-related medications, suggesting that many people with CF on Trikafta “may prioritize reducing treatment burden over maximizing lung function,” researchers said. Still, lung function continued to decline after Trikafta initiation, they reported in a real-world…